Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Women are more likely to have long-term post-COVID symptoms than men.

Heavy metals in personal care products can cause serious health issues like cancer and hair loss.

Higher hair levels of zinc and chromium were linked to less cognitive decline in very old people.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Potassium channel openers show promise for treating heart disease and other conditions, but more research is needed to fully understand their effects and safety.

Managing oxidative stress might help treat low testosterone and related chronic diseases in aging men.

Taking triterpenoids from Ganoderma lucidum over a long time can help slow down brain aging and improve overall health in mice.

Finasteride helps reduce heart enlargement in heart failure patients.

Treating hidradenitis suppurativa needs long-term care and teamwork among doctors, but there's a lack of strong guidance on how to do it.

Eating disorders are serious, often undiagnosed conditions requiring early treatment, with anorexia being the most deadly and binge-eating the most treatable.

Patients who survive critical illness often face long-lasting physical, mental, and cognitive issues, with many unable to return to work within a year.

Lifestyle changes like diet and exercise are key for treating overweight women with polycystic ovary syndrome.

Off-pump heart surgery reduces complications without affecting survival rates compared to on-pump surgery.

Obesity is linked to various skin problems and may increase the risk of skin cancer.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

PCOS is a common hormonal disorder in women, marked by symptoms like hair growth and menstrual issues, and requires personalized treatment.

Researchers found 71 genetic regions linked to male pattern baldness, which account for 38% of its genetic risk.

Genetically modified plants could be an important source of omega-3 fats to meet global needs.

Insulin resistance linked to obesity may increase COVID-19 severity.

Gene therapy has potential as a future treatment for Hutchinson-Gilford progeria syndrome.

Grey hair and baldness may be linked to COVID-19 severity, but more analysis is needed; post-infectious hair loss is related to the severity of the disease and usually recovers within 3-6 months.

Vitamin D boosts a specific gene activity in kidney cells that could improve heart and kidney function.

Non-obese women with hair loss have higher heart disease risk.

Metformin effectively improves metabolic symptoms in women with PCOS, while alfacalcidiol does not have a significant impact.

COVID-19 may affect male fertility and women might have better outcomes due to hormonal and immune differences.

Some conditions mimic PCOS symptoms and need careful diagnosis to treat potentially serious health issues.

Premature hair greying may indicate a higher risk of metabolic problems.

A genetic variant in the androgen receptor gene increases heart disease risk in women but not in men.

The document concludes that managing PCOS requires a comprehensive approach, including lifestyle changes and medication, to improve symptoms and reduce health risks.